Migraine is a debilitating neurological disease, ranking consistently among the top 10 leading causes of years lived with disability, worldwide. The main symptom of migraine is an enduring headache, along with symptoms such as severe pain on one side of the head or throbbing pain, sensitivity to light and sound, and nausea. Despite being a very common headache disorder that affects roughly 15 percent of the adult population worldwide, it remains inadequately understood and most neglected.
In Delhi, approximately 25 per cent of the population suffers from migraines, every year.
While migraine is an invisible condition, it can severely impact individuals across personal, professional and social domains, thus affecting the overall quality of life and productivity. Work-from-home, or the 'new normal,' has drastically impacted the lives of people suffering from migraines from an inability to concentrate at work to missed workdays. It has become even more urgent to ensure that individuals have the understanding and tools to effectively manage migraines.
There is a lack of understanding amongst people about the severity of migraines. In a study we recently conducted, about 50 to 60 per cent of migraineurs were undiagnosed, despite recurrent headaches. Because migraine falls on a spectrum, ranging from infrequent or mild attacks to recurrent ones, many pass it off as merely a headache'. With busy work-from-home schedules, paired with fear of contracting COVID-19 infection and difficulty in accessing in-person care, people are avoiding seeking medical help for the condition, instead attributing symptoms to associated comorbidities, such as stress or depression."
He continued, "Financial worries due to job loss or salary cuts also contribute to aggravated migraine attacks, which is more noticeable recently. The effects of migraine on one's quality of life also reportedly worsened, particularly for many migraineurs working as essential healthcare workers at this time.
Symptom neglect and failure to treat the condition can lead to migraines becoming chronic. A fundamental need is to recognize migraine as a serious condition with severe disability and adopt a holistic treatment approach. Early detection can be a key enabler of a smoother patient journey and an improved quality of life."
Here are 5 ways to manage your migraine while working from home:
Identify Risk Factors and Monitor Triggers
Migraines can begin at any age but tend to peak during one's prime productive years. Moreover, women are three times more likely to be affected than men, with prevalence peaking between the ages of 25 and 55 years.
Long hours of working from home, along with longer screen times, disrupted sleep schedules and irregular eating habits can increase stress levels. For migraineurs, such changes can become migraine triggers, exacerbating their condition. Identifying personal triggers can help individuals manage their migraines better.
Make The Right Choice for Diet and Lifestyle
Working from home can be hard, but a daily routine that optimizes your physical and mental health can help keep your migraine at bay. Eating healthy meals at appropriate times or consuming small, frequent meals throughout the day are associated with less frequent migraine headaches. Taking breaks from work at regular intervals can help you eat right and reduce eye strain owing to excessive screen use. Making modifications to your lifestyle, including smoking cessation and reduced alcohol consumption, and maintaining optimal sleeping habits and exercising regularly can be key to manage migraines. These also benefit migraine prevention and treatment.
Talk to An Expert
It is important to consult a medical specialist when you are experiencing severe headaches that disrupt your daily routine. A lot of migraineurs hesitate to seek medical help. This could be due to several reasons lack of understanding of migraine severity, lack of time due to hectic work-from-home schedules, or recently, due to a reduction in-person clinic consultations owing to the fear of Covid-19 infection. However, consulting a neurologist, even via teleconsultations, is a necessary step to diagnose your condition and understand the available options for acute and chronic management of migraine, including preventive treatment. With evidence-based information on effects across migraine intensity reduction, quality of life and ease of use, neurologists can guide you on the most suitable treatment option to prevent or reduce your migraine episodes.
Track Your Migraines
It is a good idea to maintain a diary (or download a migraine tracker app), to record the time and severity of your migraine attacks, symptoms, daily diet, exercise routines, and medications and side effects. This can help identify triggers and patterns. It can also prompt meaningful conversations with your doctor, contributing to a more holistic treatment plan, personalized to suit your work schedule.
Seek Support From Your Family, Friends or Colleagues
Living with migraines can make one feel helpless, distressed and misunderstood. But talking to your friends and family will help them understand your condition better. Having an open conversation about your migraine with your employer is a good idea, particularly to work out a schedule, with specific routine adjustments to mitigate triggers. This can help you be productive and healthy while working from home. Employers can also take the initiative -- arranging wellness programs for employees to raise awareness about migraines and how to effectively manage them at work and enhance productivity.
Migraine attacks can be challenging. Changes to your daily routine and active communication about your condition with your employer, after consulting a neurologist, can help you better manage migraines as you work from home.
Read More► The Best Ways to Treat A Sun Tan?
There has been a massive influx of patients with post Covid hair loss, said doctors here on Thursday.
The sudden onset of hair loss -- Telogen effluvium -- is caused majorly due to stress, nutritional deficiency and inflammatory reactions caused by the infectious disease, the health experts explained.
Normally a person can lose up to 100 hair per day, but due to Telogen Effluvium it can increase up to 300-400 hair per day.
"We have seen a two-fold rise in the number of patients complaining of problems related to hair loss. Post Covid-19 inflammation has been a major contributor here. The deficiencies caused by a compromised nutritional intake, sudden changes in weight, hormonal disturbances and reduced vitamin D and B12 levels are some of the major reasons for the large volumes of hair loss post Covid-19," said Shahin Nooreyezdan, Senior Consultant, Cosmetic and Plastic Surgery, Indraprastha Apollo Hospitals, New Delhi.
However, the condition, which sets in 1-1.5 months after Covid is temporary and gets better with treatment in 2-3 months.
"Reason is the interruption of hair follicle growth due to an acute infection like Covid that pushes the hair into the shedding or dead phase (telogen phase). And the dead hair shed off after a few weeks automatically," said Sachin Dhawan, Senior Consultant, Department of Dermatology, Fortis Memorial Research Institute.
"For mild cases, recovery is automatic. In severe cases, a good hair supplement with biotin and amino acids, iron and other minerals is given, along with a peptide containing serum," Dhawan added.
During the post Covid-19 recovery, people must consume a nutritious diet along with natural edible sources of vitamins and iron. Iron deficiency can further accelerate the hair loss, and consumption of a protein rich and balanced diet can itself be a solution for reducing temporarily witnessed hair fall.
Besides eating healthy and taking nutritional supplements, one should also avoid heat and chemicals for hairstyling and refrain from following a sedentary lifestyle, the doctors recommended.
"It is only after waiting for 5-6 weeks post consuming a nutritious diet that people should consult a doctor if they still encounter an excessive hair loss. Moreover, some common hair care solutions that can be administered to avoid an excessive hair loss are; use of mild, paraben and sulphate free shampoos, keeping a close check on the itchy and flaky scalp, refrain from oiling and massaging the scalp, using a wide tooth comb and seeking immediate medical intervention in case of development of bald patches and getting huge volumes of hair fall," said Kuldeep Singh, Senior Consultant Cosmetology and Plastic Surgery, Indraprastha Apollo Hospitals, New Delhi. (agency)
Washington, July 13 (IANS) The US Food and Drug Administration (FDA) added a new warning on the Johnson & Johnson Covid-19 vaccine, saying the jabhas been linked to a serious but rare side effect called Guillain-Barre syndrome.Guillain Barre syndrome is a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis, Xinhua news agency reported citing the FDA as saying.The syndrome has occurred in some people who have received the Johnson & Johnson vaccine, the FDA in a letter on Monday. In most of these people, symptoms began within 42 days following injections of the vaccine, it added.The chance of having this occur is very low, the agency said.About 100 preliminary reports of Guillain-Barre syndrome have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson jab in the US, The Washington Post quoted the Centers for Disease Control and Prevention (CDC) as saying in a statement.Of these reports, 95 were serious and required hospitalization, and one had dead.The cases have largely been reported about two weeks after vaccination and mostly in men, many aged 50 and older, according to the CDC.Johnson & Johnson said on Monday it has been in discussions with the FDA and other regulators about rare cases of Guillain-Barre syndrome.The chance of having this occur is very low, and the rate of reported cases exceeds the background rate by a small degree, the company said in a statement. --IANSksk/
New Delhi, June 24 (IANS) Having unknowingly contracted coronavirus, nine-year-old Divyanshi defeated the deadly disease within 12 days despite her critical fight with the serious life threatening post-Covid Multisystem Inflammatory Syndrome in Children (MIS-C) complication.Thanks to a dedicated team of doctors in Noida's Fortis hospital who successfully treated Divyanshi-- a resident of Noida and lucky among 25 MIS-C patients who have been treated at the healthcare facility so far with a 100 per cent success rate.The girl was admitted on June 6 and discharged from hospital on June 18.She was admitted to the hospital with a history of high fever, abdominal pain, loose motions, dehydration and falling SpO2 (also known as oxygen saturation), Fortis said in a statement, adding that she was in a very critical condition and was diagnosed to have MIS-C.MIS-C is a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs.Children with MIS-C may have a fever and various symptoms, including abdominal (gut) pain, vomiting, diarrhoea, neck pain, rash, bloodshot eyes, or feeling extra tired. However, many children with MIS-C had the virus that causes Covid-19 or had been around someone with Covid-19.At the time of her admission in the hospital, the girl's parents were not aware that she had contracted Covid in the past.Ashutosh Sinha, Additional Director (Paediatrics), Fortis Hospital Noida, said: "The child was in extremely critical condition when she reached the hospital. We highly suspected MIS-C which is usually a post Covid complication, but the parents shared that there was no history of Covid. We knew we had to act fast, and we immediately sent her blood samples to our labs (along with an antibody test)."Without waiting for the reports, we took a call to treat her according to MIS-C syndrome as other treatment had already failed and began giving her steroids and other supportive care, said the doctor, adding "we prepared her parents for the possibility that she might need to be put onto ventilator support"."She started showing symptomatic improvement by the next morning and her reports also confirmed the MIS-C diagnosis."It was also revealed that the girl had developed antibodies against Covid which established that she had unknowingly suffered from Covid in the past. "Timely decisions and quick action enabled us to save her life."The doctor advised parents to act early if they see the above signs and symptoms in their children and to get in touch with their paediatrician as "early diagnosis and treatment is the key to successful treatment of this condition".Mohit Singh (Head-SBU) Fortis Hospital Noida said, "The team at the hospital were quick to diagnose the patient and provide timely medical attention. Their patient centric approach saved the patient's life. The case was managed extremely well by Ashutosh Sinha and his team."Fortis Healthcare Ltd is one of the largest healthcare organisations in the country with 36 healthcare facilities (including projects under development).--IANSrak/sdr/bg
New Delhi, June 22 (IANS) Eleven individuals who received the AstraZeneca-Oxford Covid-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians in India and England have reported in two separate studies.The studies, published in the peer-reviewed medical journal Annals of Neurology, describe an unusual variant of Guillain-Barre syndrome characterised by prominent facial weakness. All the eleven cases were among people who had received that vaccine 10-22 days earlier.Seven cases were reported from a regional medical center in Kerala, India, where approximately 1.2 million people were vaccinated with the AstraZeneca Covid-19 vaccine till April 22. The cases occurred within two weeks of the first dose of vaccination."Six out of the seven patients progressed to areflexic quadriplegia and required mechanical ventilatory support," said Boby Varkey Maramattom, from the Department of Neurology, Aster Medcity, Kochi, Kerala."The frequency of GBS was 1.4 to 10 fold higher than that expected in this period for a population of this magnitude. In addition, the frequency of bilateral facial weakness, which typically occurs in less than 20 per cent of GBS cases, suggests a pattern associated with the vaccination," he added.Four cases were reported from Nottingham, England, in which approximately 700,000 people received the same vaccine. These were characterised by bifacial weakness with a paraesthesias variant of GBS occurring within three weeks of vaccination with the Oxford-AstraZeneca SARS-CoV-2 vaccine."This rare neurological syndrome has previously been reported in association with SARS-CoV-2 infection itself. Our cases were given either intravenous immunoglobulin, oral steroids, or no treatment," said Jonathan Rhys Evans, Department of Neurology, Nottingham University Hospitals NHS Trust, UK."If the link is causal it could be due to a cross-reactive immune response to the SARS-CoV-2 spike protein and components of the peripheral immune system," wrote the authors of the report from England.While the benefits of vaccination substantially outweigh the risk of this relatively rare outcome (5.8 per million), the research groups stressed that clinicians should be alert to this possible adverse event and look for this rare neurological syndrome following administration of Covid-19 vaccines."We suggest vigilance for cases of bifacial weakness with paraesthesias variant GBS following vaccination for SARS-CoV-2 and that post-vaccination surveillance programmes ensure robust data capture of this outcome, to assess for causality," Evans said.--IANSrvt/dpb
Srinagar, June 14 (IANS) A 37-year old rape accused lodged in a Jammu and Kashmir jail in Kupwara district has died in the hospital on Monday of post Covid complications."He was under quarantine after testing positive for Covid-19. He had recently tested negative. He was shifted to hospital yesterday where he succumbed," jail officials said in Kupwara district.The victim has been identified as Lateef Ahmad Mir of Sopore. He was arrested as an accused for rape and wrong confinement by police."He was in judicial custody in Kupwara district jail since February 5, 2021," officials said.--IANSamita/in